Literature DB >> 9615760

High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.

C Huiping1, G Eiriksdottir, A Sigurdsson, J R Sigurgeirsdottir, R B Barkardottir, V Egilsson, S Ingvarsson.   

Abstract

Human primary breast cancers were analysed for somatic loss of heterozygosity (LOH) at chromosome 18 with 15 polymorphic microsatellite markers. LOH was observed in 148 of the 228 cases analyzed, (65%). Three smallest common deletion regions (SCDR) were detected on the long arm of chromosome 18. The marker D18S51 at the region 18q22 showed the highest LOH (42%). Tumors with and without LOH at 18q were tested for association with clinico-pathological features of the tumors, such as estrogen and progesterone receptor content, age at diagnosis, tumor size, node status, histological type, S-phase fraction, DNA ploidy and LOH at other chromosomal regions. A significant association was found between LOH at 18q and high S-phase fraction (99.9% confidence interval) and low progesterone receptor content (99% confidence interval). Furthermore, an association was found between LOH at 18q and LOH at 1p, 7q, 9p, 13q and 17q. We conclude that there are three separate LOH target regions at chromosome 18q, and that inactivation of one or more genes at these regions might be important for human breast carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615760

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Allelic imbalances of chromosomes 8p and 18q and their roles in distant relapse of early stage, node-negative breast cancer.

Authors:  Aki Morikawa; Tanisha Y Williams; Luc Dirix; Cecile Colpaert; Michael Goodman; Robert H Lyles; Diansheng Zhong; Wei Zhou
Journal:  Breast Cancer Res       Date:  2005-11-02       Impact factor: 6.466

2.  Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.

Authors:  C Huiping; J R Sigurgeirsdottir; J G Jonasson; G Eiriksdottir; J T Johannsdottir; V Egilsson; S Ingvarsson
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

3.  Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer.

Authors:  Ewelina Szymańska; Paulina Nowak; Krzysztof Kolmus; Magdalena Cybulska; Krzysztof Goryca; Edyta Derezińska-Wołek; Anna Szumera-Ciećkiewicz; Marta Brewińska-Olchowik; Aleksandra Grochowska; Katarzyna Piwocka; Monika Prochorec-Sobieszek; Michał Mikula; Marta Miączyńska
Journal:  EMBO Mol Med       Date:  2020-01-13       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.